与激素避孕相关的抑郁史可提示产后抑郁风险
该丹麦队列研究纳入188 648名首次分娩女性,比较激素避孕相关抑郁史与非相关抑郁史者的产后抑郁风险。结果显示,激素避孕相关抑郁史者产后6个月内抑郁风险更高(粗OR 1.42,95%CI 1.24-1.64;调整OR 1.35,95%CI 1.17-1.56),提示其可作为产后抑郁风险分层的新指标。
要点
- 激素避孕相关抑郁史者产后抑郁风险高于非相关抑郁史者(调整OR 1.35)。
- 该关联支持存在激素敏感女性亚组,可辅助产后抑郁风险分层。
- 研究基于丹麦健康登记数据,产后抑郁定义为首次分娩后6个月内抑郁诊断或抗抑郁药处方。
核心结论
- 激素避孕相关抑郁史与产后抑郁风险升高相关,支持其作为产后抑郁易感性指标。
研究设计与样本
- 基于丹麦健康登记数据的队列研究,收集1995年1月1日至2017年12月31日数据。
- 纳入1978年后出生、1996年1月1日至2017年6月30日首次分娩的女性,最终分析188 648名。
- 排除从未使用激素避孕者及1996年前或分娩前12个月内已有抑郁发作者。
主要发现
- 5722名(3.0%)有激素避孕相关抑郁史,平均年龄26.7岁(SD 3.9)。
- 18 431名(9.8%)有非激素避孕相关抑郁史,平均年龄27.1岁(SD 3.8)。
- 激素避孕相关抑郁史者产后抑郁风险更高:粗OR 1.42(95%CI 1.24-1.64),调整OR 1.35(95%CI 1.17-1.56)。
关键数值与推荐
- 激素避孕相关抑郁定义为开始激素避孕暴露后6个月内出现的抑郁。
- 抑郁定义为医院抑郁诊断或开具抗抑郁药处方。
- 产后抑郁定义为首次分娩后6个月内出现抑郁。
临床怎么用
- 询问育龄女性激素避孕使用后是否出现抑郁,可辅助识别产后抑郁高危人群。
- 对有激素避孕相关抑郁史者,产前可加强产后抑郁监测与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hormonal sensitivity may contribute to the risk of depression in some women, as observed during the premenstrual, postpartum, and perimenopausal phases, and when initiating hormonal contraception (HC). However, little evidence exists to support that such depressive episodes are linked across the reproductive life span. OBJECTIVE: To determine whether prior depression associated with HC initiation is coupled with a higher risk of postpartum depression (PPD) than prior depression not associated with HC initiation. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used Danish health registry data collected from January 1, 1995, through December 31, 2017, and analyzed from March 1, 2021, through January 1, 2023. All women living in Denmark born after 1978 with their first delivery between January 1, 1996, and June 30, 2017, were eligible for inclusion; 269 354 met these criteria. Women were then excluded if they had never used HC or if they had a depressive episode before 1996 or within 12 months prior to delivery. EXPOSURES: Prior depression associated with vs not associated with HC initiation, ie, if developed within 6 months after start of an HC exposure or not. Depression was defined as a hospital diagnosis of depression or filling a prescription for antidepressant medication. MAIN OUTCOMES AND MEASURES: Crude and adjusted odds ratios (ORs) were calculated for the incidence of PPD defined as the development of depression within 6 months after first delivery. RESULTS: Of 188 648 first-time mothers, 5722 (3.0%) (mean [SD] age, 26.7 [3.9] years) had a history of depression associated with initiation of HC use, and 18 431 (9.8%) (mean [SD] age, 27.1 [3.8] years) had a history of depression not associated with the initiation of HC. Women with HC-associated depression had a higher risk of PPD than women with prior non-HC-associated depression (crude OR, 1.42 [95% CI, 1.24-1.64]; adjusted OR, 1.35 [95% CI, 1.17-1.56]). CONCLUSIONS AND RELEVANCE: These findings suggest that a history of HC-associated depression may be associated with a higher risk of PPD, supporting that HC-associated depression may indicate PPD susceptibility. This finding offers a novel strategy in clinical PPD risk stratification and points to the existence of a hormone-sensitive subgroup of women.
引用
- Larsen SV, Mikkelsen AP, Lidegaard Ø, et al. Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression. JAMA Psychiatry. 2023. PMID: 37099310. doi:10.1001/jamapsychiatry.2023.0807
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。